Skip to content
Our Oregon Local Jurisdiction Tracker is available now.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Research Review

      A monthly review of the most important psychedelics research.

      Review Archive

      News & Interviews

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Legalization & Decriminalization Tracker

      Mapping psychedelic drug policy reform across the United States

      Explore the Tracker
      New: Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Canadian Patent Grant Strengthens Small Pharma’s International Position

Canadian Patent Grant Strengthens Small Pharma’s International Position

  • Post published:August 4, 2022
  • Post category:Press Release
Read more about the article U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation

U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation

  • Post published:July 27, 2022
  • Post category:Press Release
Read more about the article George Tziras to Succeed Peter Rands as Small Pharma  Chief Executive Officer

George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer

  • Post published:July 18, 2022
  • Post category:Press Release
Read more about the article Small Pharma Reports Fiscal First Quarter 2023 Highlights

Small Pharma Reports Fiscal First Quarter 2023 Highlights

  • Post published:July 17, 2022
  • Post category:Press Release
Read more about the article Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

  • Post published:June 22, 2022
  • Post category:Press Release
Read more about the article Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

  • Post published:June 9, 2022
  • Post category:Press Release
Read more about the article Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

  • Post published:March 10, 2022
  • Post category:Press Release
Read more about the article World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

  • Post published:February 22, 2022
  • Post category:Press Release
Read more about the article Small Pharma Reports Fiscal Third Quarter 2021 Highlights

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

  • Post published:January 31, 2022
  • Post category:Press Release
Read more about the article Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

  • Post published:November 18, 2021
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.